Checkpoint Blockade Finally Breaks Through in Ovarian Cancer

By News Health
1 month Ago

(MedPage Today) — BERLIN — After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall survival (OS) benefit in ovarian cancer, phase III study results showed.
KEYNOTE-B96 enrolled patients…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118021

Author :

Publish date : 2025-10-19 18:10:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Congo Declares Its Latest Ebola Outbreak Over, After 43 Deaths

Trump's 'MRI' Report Questioned; Luigi Mangione in Court; 33 Dead in Outbreaks

Approaching End-of-Life Discussions With Hospital Patients

Pediatric HS Has Low Prevalence, Delayed Diagnosis

Low FODMAP Diet for IBS? Check for Eating Disorders First

Does Mental Illness Affect Emergency Response to Chest Pain?